SCHEMBL6690786

SCHEMBL6690786

O=Cc1ccc(OCc2cc(F)cc(F)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.64
BACE1 P56817 3/20 0.64
RAB9A P51151 1/20 0.58
MAOB P27338 6/20 0.55
MAOA P21397 3/20 0.55
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP14 P50281 1/20 0.46
ADAM17 P78536 1/20 0.46
ACHE P22303 1/20 0.46
KMT2A Q03164 2/20 0.45
NR4A2 P43354 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28188470 0.86 MAOA (0.60) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL1347334 0.85 MAOB (0.76) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL29464145 0.85 MAOB (0.76) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL865238 0.84 MAOB (0.67) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL23223734 0.81 RAB9A (0.69) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL11614936 0.81 RAB9A (0.69) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL12578006 0.81 MAOA (0.48) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL15774625 0.80 RAB9A (0.63) GSK3BBACE1RAB9AMAOBMAOA
Acetaldehyde SCHEMBL28912782 0.80 MAOB (0.61) GSK3BBACE1RAB9AMAOBMAOA
SCHEMBL348599 0.79 RAB9A (0.58) GSK3BBACE1RAB9AMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087125-A1 AMINO ACID DERIVATIVES AS INHIBITORS OF MAMMALIAN SODIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2004-10-14 WO disclosed